TY - JOUR
T1 - Homozygous SGCB splice-site variant causes isolated dilated cardiomyopathy through sarcoglycan complex destabilization in East Asians
AU - Li, Fangfang
AU - Shinomiya, Haruki
AU - Kuramoto, Yuki
AU - Kanaoka, Koshiro
AU - Sakahashi, Yuji
AU - Ishihara, Yasuki
AU - Kioka, Hidetaka
AU - Ide, Seiko
AU - Yamaguchi-Kabata, Yumi
AU - Tadaka, Shu
AU - Motoike, Ikuko N.
AU - Kinoshita, Kengo
AU - Ohneda, Kinuko
AU - Sakurai, Hidetoshi
AU - Okumura, Takahiro
AU - Miyashita, Yohei
AU - Jojima, Kota
AU - Kato, Hisakazu
AU - Matsuoka, Ken
AU - Tanabe, Kazuya
AU - Nishimura, Shunsuke
AU - Takashima, Seiji
AU - Asano, Yoshihiro
AU - Sakata, Yasushi
N1 - Publisher Copyright:
© 2026, Li et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
PY - 2026/4/14
Y1 - 2026/4/14
N2 - Dilated cardiomyopathy (DCM) is a genetically heterogeneous disorder, characterized by ventricular dilatation and impaired systolic function, leading to heart failure and sudden cardiac death. Despite advances in genomic technologies, the genetic cause of DCM remains unidentified in more than half of the cases. Here, we performed an integrative analysis of genomic and transcriptomic data from patient-derived cardiac tissue to identify causative variants in genetically undiagnosed DCM. This approach enabled us to identify a homozygous splice-site variant (c.243+6T>A) in the sarcoglycan gene SGCB, which results in exon 2 skipping. This variant was significantly enriched in patients with DCM compared with the general population, with consistent genotype–phenotype correlations observed across multiple families. Protein-level analysis of cardiac tissue from homozygous individuals revealed loss of β-sarcoglycan, the protein product of SGCB, and destabilization of the sarcoglycan complex. Although SGCB has been previously associated with limb-girdle muscular dystrophy, these homozygous individuals showed no biochemical or clinical signs of skeletal muscle involvement, indicating an absence of myopathy. Compared with variant-negative patients with DCM, homozygous individuals also had a higher risk of early-onset adverse cardiac events. Together, these findings identify c.243+6T>A in SGCB as a cause of isolated DCM associated with unfavorable clinical outcomes.
AB - Dilated cardiomyopathy (DCM) is a genetically heterogeneous disorder, characterized by ventricular dilatation and impaired systolic function, leading to heart failure and sudden cardiac death. Despite advances in genomic technologies, the genetic cause of DCM remains unidentified in more than half of the cases. Here, we performed an integrative analysis of genomic and transcriptomic data from patient-derived cardiac tissue to identify causative variants in genetically undiagnosed DCM. This approach enabled us to identify a homozygous splice-site variant (c.243+6T>A) in the sarcoglycan gene SGCB, which results in exon 2 skipping. This variant was significantly enriched in patients with DCM compared with the general population, with consistent genotype–phenotype correlations observed across multiple families. Protein-level analysis of cardiac tissue from homozygous individuals revealed loss of β-sarcoglycan, the protein product of SGCB, and destabilization of the sarcoglycan complex. Although SGCB has been previously associated with limb-girdle muscular dystrophy, these homozygous individuals showed no biochemical or clinical signs of skeletal muscle involvement, indicating an absence of myopathy. Compared with variant-negative patients with DCM, homozygous individuals also had a higher risk of early-onset adverse cardiac events. Together, these findings identify c.243+6T>A in SGCB as a cause of isolated DCM associated with unfavorable clinical outcomes.
UR - https://www.scopus.com/pages/publications/105040842841
UR - https://www.scopus.com/pages/publications/105040842841#tab=citedBy
U2 - 10.1172/JCI198675
DO - 10.1172/JCI198675
M3 - Article
C2 - 42222889
AN - SCOPUS:105040842841
SN - 0021-9738
VL - 136
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 11
M1 - e198675
ER -